Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Accelerated Approval: Makena Real-World Evidence Insufficient To Verify Clinical Benefit, CDER Says
Apr 21 2022
•
By
Sue Sutter
CDER has closed the door on any bid by Covis to rely solely on real-world evidence to confirm Makena's clinical benefit. • Source: Alamy
More from Real-World Evidence
More from Clinical Trials